Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12Bristol Myers Squibb

02 2Celgene Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

02

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

03

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

04

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

05

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Injectable Solution

Dosage Strength : 75MG

Packaging :

Approval Date : 18-08-2020

Application Number : 1201452002

Regulatory Info : Authorized

Registration Country : Spain

blank

06

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Injectable Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 18-08-2020

Application Number : 1201452001

Regulatory Info : Authorized

Registration Country : Spain

blank

07

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 25mg

Packaging :

Approval Date : 25-06-2020

Application Number : 28106269119

Regulatory Info : Prescription

Registration Country : Denmark

blank

08

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 75mg

Packaging :

Approval Date : 25-06-2020

Application Number : 28106269219

Regulatory Info : Prescription

Registration Country : Denmark

blank

09

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 25mg

Packaging :

Approval Date : 25-06-2020

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

10

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 75mg

Packaging :

Approval Date : 25-06-2020

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

11

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

LUSPATERCEPT

Brand Name : REBLOZYL

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 25MG/VIAL

Packaging :

Approval Date :

Application Number : 2505541

Regulatory Info : Prescription

Registration Country : Canada

blank

12

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

LUSPATERCEPT

Brand Name : REBLOZYL

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 75MG/VIAL

Packaging :

Approval Date :

Application Number : 2505568

Regulatory Info : Prescription

Registration Country : Canada

blank

13

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

LUSPATERCEPT-AAMT

Brand Name : REBLOZYL

Dosage Form : POWDER;SUBCUTANEOUS

Dosage Strength : 25MG/VIAL

Packaging :

Approval Date :

Application Number : 761136

Regulatory Info :

Registration Country : USA

blank

14

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

LUSPATERCEPT-AAMT

Brand Name : REBLOZYL

Dosage Form : POWDER;SUBCUTANEOUS

Dosage Strength : 75MG/VIAL

Packaging :

Approval Date :

Application Number : 761136

Regulatory Info :

Registration Country : USA

blank